Back to Search Start Over

The JAK2-STAT pathway epigenetically regulates tolerized genes during the first encounter with bacterial antigens

Authors :
Damiana Álvarez-Errico
Esteban Ballestar
Antonio Garcia-Gomez
Octavio Morante-Palacios
Francesc Català-Moll
Mónica Martínez-Gallo
Juan Carlos Ruiz-Rodríguez
Adolfo Ruiz-Sanmartín
Ricard Ferrer-Roca
Laura Ciudad
Clara Lorente-Sorolla
Publication Year :
2020
Publisher :
Cold Spring Harbor Laboratory, 2020.

Abstract

Microbial challenges, such as widespread bacterial infection, induce endotoxin tolerance. This state of hyporesponsiveness to subsequent infections is mainly displayed by monocytes and macrophages. Endotoxin tolerance is generally acquired following a septic episode. In this study, we investigated DNA methylation changes during the acquisition of in vitro tolerance. We identified a set of TET2-mediated demethylation events that are specific to toll-like receptor (TLR) 2 and TLR4 stimulation. Lipopolysaccharide (LPS)-specific demethylation occurs at genomic sites that have low accessibility in quiescent monocytes, concomitantly with the transcriptional activation of many inflammation-related genes, and they are enriched in binding motifs for several signal transducer and activator of transcription (STAT) family members. Indeed, STAT1, STAT3 and STAT5, elements of the JAK2 pathway, are phosphorylated in association with the acquisition of endotoxin tolerance. Inhibition of the JAK2 pathway impairs the activation of tolerized genes on the first encounter with LPS. This is evidence of a crucial role for this pathway in determining the initial response of these genes to bacterial antigens and provides a pharmacological target to prevent exacerbated responses, allowing regulated responses upon subsequent challenges. Finally, we assess the pathological relevance of the JAK2 pathway in monocytes from patients with sepsis.

Details

Database :
OpenAIRE
Accession number :
edsair.doi...........ac5bed3ba8a69feac9a5b21f0489fde9
Full Text :
https://doi.org/10.1101/2020.10.16.342717